Innovating Novel Therapeutics and Bettering Lives


mabwell home 01 hand

Unconventional Antibody Therapeutics

We are striving to improve the lives of people with rare, debilitating diseases by leveraging the promise of science into novel antibody therapeutics.

Our Company


The Science Behind Our Approach

Following rigorous research and development guidelines, we are advancing antibody drugs that address unmet medical needs. We pinpoint targets, uncover lead molecules, and leverage antibody engineering to boost the chance of favorable outcomes.

mabwell home 02 genes

What’s Happening
at Mabwell Therapeutics


January 20, 2023

$412.5 million! Mabwell Announces Exclusive Licensing Agreement with DISC MEDICINE, INC. for Innovative Drug Candidates of Hematologic Diseases

Read more

January 5, 2023

Mabwell Announces the NMPA approval of 9MW3011 (FIC) for IND

Read more

Want to be part of the journey?